IMMUNOLOGICAL BIOMARKERS AND PROGNOSIS OF ENDOMETRIAL CANCER: A META-ANALYSIS
Authors:
- Emama Arshad AbbasiEAEmama Arshad Abbasi
- Nisha Hamid AwanaNANisha Hamid Awana
- Soffia KhursheedSKSoffia Khursheed
- Sohail AhmedSASohail Ahmed
- Jahanzeb AhmedJAJahanzeb Ahmed
- Amna AkbarAAAmna Akbar
- Sabahat TasneemSTSabahat Tasneem
- Mohammad Saleem KhanMKMohammad Saleem Khan
- Sarosh Khan JadoonSJSarosh Khan Jadoon
Open Access
- 11 November 2023
- journal article
- review article
- Published by Green Publication
- Vol. 30 (18) , 2048-2059
Abstract
Objective: This research is to explore the relationship in immune related biomarkers and prognosis in endometrial cancer (EC). Method: This article searched relevant databases and literature, and ultimately included 13 articles for meta-analysis. During the literature screening process, irrelevant literature, as well as literature published in comments and academic conferences were excluded. Among the included literature, there are 6 articles related to miR-421 and 7 articles related to miR-548ag. The data processing of Meta-analysis adopts statistical methods. Result: The combined specificity and SROC curve results of meta-analysis showed that miR-421 and miR-548ag possess high diagnostic value for EC. At the same time, sensitivity analysis was conducted on the overall survival rate of OS, and no significant impact was found on combined HR and 95% CI in any study. This indicates that miR-421 and miR-548a possess an essential influence on the prognosis of EC and demonstrates the reliability of this analysis. Conclusion: The relevant outcomes suggest that miR-421 and miR-548ag may be biomarkers for the prognosis of endometrial cancer. These findings have important guiding significance for a deeper understanding of the pathogenesis, pathological and physiological changes, and clinical treatment of endometrial cancer. It is essential to conduct more research for validating the role of these biomarkers in the prognosis of endometrial cancer.Keywords
This publication has 12 references indexed in Scilit:
- Long-term transplantation human menstrual blood mesenchymal stem cell loaded collagen scaffolds repair endometrium histological injuryReproductive Toxicology, 2022
- Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)Gynecologic Oncology, 2022
- Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classificationGynecologic Oncology, 2022
- Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationGynecologic Oncology, 2022
- Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancerBiochemical and Biophysical Research Communications, 2022
- OP017/#81 Endometrial cancer prognosis in women with endometriosis and adenomyosis. A retrospective nationwide cohort study of 40,847 womenInternational Journal of Gynecological Cancer, 2021
- The Levonorgestrel Intrauterine System for Prevention of Endometrial Cancer in Women With Obesity: A Cost-effectiveness StudyObstetrical & Gynecological Survey, 2021
- Optimization of diagnostic studies in patients with adenomiosis and/or hyperplastic processes of endometriumReproductive Endocrinology, 2021
- Clinical and anamnestic data and morphofunctional characteristics of the endometrium in women with uterine developmental anomaliesJournal of obstetrics and women's diseases, 2021
- The relationship between KRAS LCS6 polymorphism and endometrium cancerJournal of Obstetrics and Gynaecology, 2019